Serious problem! Innovative solutions!

In the United States, there are approximately 356,000 out-of-hospital cardiac arrests annually.

The survival rate to hospital discharge for OHCA in the U.S. is around 10%, indicating a high death rate of about 90%.

With approximately 100,000 deaths caused by medical errors during an emergengy “Code Blue.”

PathFree Technologies aims to solve the problems that cause these medical errors.

This Website is not an offer to sell a security, any offer must be accompanied by PathFree Technologies Corporation’s Private Placement Memorandum
This Website is not an offer to sell a security, any offer must be accompanied by PathFree Technologies Corporation’s Private Placement Memorandum

Current Market Size: USD 16.3 billion

USD 14.6 billion to USD 16.3 billion in 2023: This range reflects estimates from different market research firms like MarketsandMarkets, Precedence Research, and Binariks. From USD 11 billion in 2021: This is from Statista, and shows the market’s growth over the past couple of years.

Projected growth: CAGR of 47.6% through 2030

CAGR of 37% to 47.6% from 2022 to 2030: This indicates rapid and significant growth in the market over the next few years. Reaches USD 102.7 billion to USD 187.95 billion by 2028-2030: These figures reflect the expected market size in the coming years based on projections from different sources.

PathFree Technologies Corporation introduces its Equity Offering

PathFree Technologies is offering up to 5,000,000 shares of common stock at a purchase price of $5.00 per share, purchasers of stock are entitled to enter PathFree Technologies’ Warrant Program.

This Business Plan is not an offer to sell a security, any offer must be accompanied by PathFree Technologies Corporation’s Private Placement Memorandum

This Business Plan is not an offer to sell a security, any offer must be accompanied by PathFree Technologies Corporation’s Private Placement Memorandum

STONEBRIDGE Valuations

Now valued at over $1 Billion

Contact us @ 1 (888) 83-PATHFREE

2024 AiMediQ Brand offers Emergency Medical Solutions

Our comprehensive suite of innovative medical devices caters to a diverse clientele, ranging from hospitals to emergency responders.

PathFree AiMediQ AiCart

  • Smart Integration: Utilizes artificial intelligence, machine learning, and automation to optimize emergency medical procedures like CPR and ACLS.
  • Professional Assistance: Aims to support medical professionals by offering efficient and intelligent assistance during critical care situations.
  • Innovative Healthcare Solution: Represents PathFree Technologies’ dedication to advancing healthcare through innovative technology, enhancing patient care during emergencies.

PathFree AiMediQ AiMini

  • Compact and Mobile: The AiMediQ AiMini is a compact, mobile unit that brings the advanced features of the AiCart to locations outside of the hospital, making it highly deployable for emergency medical response in various settings such as schools and concerts.
  • Technology-Driven: Utilizes cutting-edge technologies like artificial intelligence (AI), machine learning (ML), and the Internet of Things (IoT) to improve emergency response efficiency, reduce human errors, and enhance patient outcomes during cardiopulmonary arrest situations.​
  • Sustainability and Accessibility: Committed to sustainability and global accessibility, the AiMini is eco-friendly, reusable, and recyclable, designed to be intuitive for healthcare professionals worldwide, ensuring high-quality care is accessible everywhere​​.

PathFree AiMediQ MobileER

  • Revolutionary Emergency Response: AiMediQ MobileER uses advanced technology for autonomous navigation to emergency sites, offering immediate medical support in remote areas​​.
  • Sustainability and Global Reach: PathFree emphasizes eco-friendly solutions, aiming for global accessibility of its medical devices to enhance healthcare delivery​​.
  • Leadership and Innovation: Under Perry M. Brunette’s leadership, PathFree focuses on minimizing human error in emergency and ACLS scenarios with AI-powered devices​​.

PathFree AiMediQ MediQ

  • Data-Driven Emergency Response: PathFree Technologies’ AiMediQ MediQ integrates AI to offer a sophisticated emergency response system, merging the capabilities of a comprehensive medical kit with advanced technology to address various medical emergencies efficiently.
  • Innovative and Portable: The AiMediQ MediQ, inspired by the AiMediQ AiCart, is designed to be compact and portable, enhancing medical response efficiency in critical situations through its cutting-edge features.
  • Advanced Technology for Better Outcomes: Through the use of AI, machine learning, and predictive analytics, PathFree Technologies aims to significantly enhance patient outcomes, especially in critical care scenarios like CPR and ACLS.
This Website is not an offer to sell a security, any offer must be accompanied by PathFree Technologies Corporation’s Private Placement Memorandum

“In the realm of ACLS and CPR, every second counts, and every action matters. We’re pioneering AI-integrated medical solutions to empower healthcare professionals with the tools they need for faster, more accurate decision-making in critical situations.”

Perry M. Brunette

Co-founder / CEO / CFO, PathFree Technologies

US Market Insights Q1 2024

Reporting entity: PitchBook

This Website is not an offer to sell a security, any offer must be accompanied by PathFree Technologies Corporation’s Private Placement Memorandum

Watch, Read, Listen

No posts were found.

Join our subscribers

Stay in the loop with everything you need to know.